Jackson Creek Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
SCM
TCM
GACM
Jackson Creek Investment Advisors's ANIP Position: Q2 2026 in Review
Jackson Creek Investment Advisors reduced its ANI Pharmaceuticals (ANIP) stake by 28% in Q2 2026, selling an estimated $442K and leaving 14,298 shares worth $1.13M. The position accounts for 0.38% of the portfolio, ranked #114.
Jackson Creek Investment Advisors first reported a position in ANIP in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.95M in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Jackson Creek Investment Advisors held 14,298 shares of ANI Pharmaceuticals worth $1.13M as of Q2 2026.
- Jackson Creek Investment Advisors sold 5,515 ANI Pharmaceuticals shares in Q2 2026, an estimated $442K.
- ANI Pharmaceuticals made up 0.38% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #114 holding.
- Jackson Creek Investment Advisors first reported a position in ANI Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
- Jackson Creek Investment Advisors's ANI Pharmaceuticals position peaked at $1.95M in Q3 2025.
- 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.